Nicole M Carter Selected Research

Cefpodoxime Proxetil (Vantin)

1/2021	Ceftazidime-Avibactam Resistance Mutations V240G, D179Y, and D179Y/T243M in KPC-3 β-Lactamase Do Not Alter Cefpodoxime-ETX1317 Susceptibility.
11/2020	Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole M Carter Research Topics

Disease

4	Infections 11/2023 - 11/2020
1	Bacterial Pneumonia 12/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021
1	Gram-Negative Bacterial Infections 11/2020
1	Demyelinating Diseases (Demyelinating Disease) 12/2010
1	Experimental Autoimmune Neuritis 12/2010

Drug/Important Bio-Agent (IBA)

4	LactamsIBA 12/2023 - 11/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 11/2020
2	sulbactam-durlobactamIBA 12/2023 - 11/2023
2	Carbapenems (Carbapenem Antibiotics)IBA 11/2023 - 11/2020
2	ProdrugsIBA 01/2021 - 11/2020
2	Cefpodoxime Proxetil (Vantin)FDA LinkGeneric 01/2021 - 11/2020
1	Calcineurin InhibitorsIBA 01/2021
1	EstersIBA 11/2020
1	Complement System Proteins (Complement)IBA 12/2010
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 12/2010
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2010
1	Complement C6 (Complement 6)IBA 12/2010
1	P-SelectinIBA 12/2010

Therapy/Procedure

2	Therapeutics 12/2020 - 11/2020
1	Mechanical Ventilators (Ventilator) 12/2023